CREB1 and neoplasm: This suggested to us that aberrant overexpression of CREB1 in gastric cancer may be partially due to the downregulation of miR-27b/miR-200b in gastric cancer, and miR-27b/miR-200b could be potential CREB1 inhibitors to suppress carcinogenesis and tumor progression.